Edesa Biotech, Inc. (EDSA)

USD 1.82

(-2.67%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - 328.8 Thousand 410.87 Thousand 211.84 Thousand
Cost of Revenue 183.47 Thousand 118.18 Thousand 118.78 Thousand 17.6 Thousand 101.28 Thousand 445.32 Thousand
Gross Profit -183.47 Thousand -118.18 Thousand -118.78 Thousand 311.2 Thousand 309.58 Thousand -233.47 Thousand
Operating Expenses 9.22 Million 17.59 Million 13.34 Million 6.71 Million 3.14 Million 4.84 Million
Selling, General and Administrative Expenses 4.24 Million 5.03 Million 5.73 Million 3.38 Million 2.04 Million 2.75 Million
Research and Development Expenses 4.79 Million 13.33 Million 17.94 Million 3.32 Million 1.09 Million 2.08 Million
Other Expenses - -780.25 Thousand -10.34 Million 37.41 Thousand - -
Cost and Expenses 9.22 Million 17.59 Million 13.34 Million 6.72 Million 3.24 Million 5.29 Million
Operating Income -9.22 Million -18.37 Million -23.68 Million -6.4 Million -2.83 Million -5.07 Million
Interest Expense - - - - - -
Income Tax Expense 800.00 800.00 800.00 800.00 -55.4 Thousand 800.00
Earnings before Tax -8.37 Million -17.54 Million -13.34 Million -6.36 Million -2.77 Million -5.03 Million
Net Income -8.37 Million -17.54 Million -13.34 Million -6.36 Million -2.72 Million -5.03 Million
Earnings Per Share Basic -2.93 -8.37 -7.74 -5.18 -4.15 -10.54
Earnings Per Share Diluted -2.93 -8.37 -7.73 -5.18 -4.15 -10.54
Weighted Average Shares Outstanding 2.85 Million 2.09 Million 1.72 Million 1.22 Million 655 Thousand 478.22 Thousand
Weighted Average Shares Outstanding (Diluted) 2.85 Million 2.09 Million 1.72 Million 1.22 Million 655.31 Thousand 478.22 Thousand
Gross Margin - - - 0.95 0.75 -1.10
EBIT Margin - - - -19.47 -6.88 -23.27
Profit Margin - - - -19.36 -6.62 -23.79
EBITDA -8.19 Million -17.42 Million -13.22 Million -6.34 Million -2.82 Million -4.84 Million
Earnings Before Tax Margin - - - -19.47 -6.89 -23.97

Income Statement Charts